Possibilities for personalized cancer vaccines revealed at ESMO symposium
11/25/2014
The possibilities for personalised vaccines in all types of cancer were revealed in a lecture from Dr Harpreet Singh at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.
Women with mental illness are 40 percent less likely to receive routine cancer screenings
11/25/2014
Women with symptoms of serious mental illness are significantly less likely to receive three routine cancer screenings - Pap tests, mammograms and clinical breast exams - than women in the general...
Women with mental illness are 40 percent less likely to receive routine cancer screenings
11/25/2014
Women with symptoms of serious mental illness are significantly less likely to receive three routine cancer screenings - Pap tests, mammograms and clinical breast exams - than women in the general...
Novel compound seen as enhancing the cancer-killing power of anti-tumor drugs
11/25/2014
Recent studies showing acid ceramidase (AC) to be upregulated in melanoma, lung and prostate cancers have made the enzyme a desired target for novel synthetic inhibitor compounds.
Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC
11/25/2014
In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers tod the 26th EORTC-NCI-AACR1 Symposium on...
Ultrasound able to penetrate bone, metal, with new technique
11/25/2014
Researchers from North Carolina State University have developed a technique that allows ultrasound to penetrate bone or metal, using customized structures that offset the distortion usually caused by...
STING pathway key to tumor immunity
11/25/2014
A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system...
A derivative of vitamin B3 found to prevent liver cancer in mice
11/25/2014
Liver cancer is one of the most frequent cancers in the world, and with the worst prognosis; according to the World Health Organisation (WHO), in 2012, 745,000 deaths were registered worldwide due to...
Melanoma immunotherapy inhibits tumor growth & increases survival
11/24/2014
Inovio Pharmaceuticals, Inc. has announced its newest DNA-based cancer immunotherapy targeting melanoma induced a robust and broad immune response in animals and directed cancer-killing T cells...
Immune checkpoint inhibitors may work in brain cancers
11/24/2014
New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva...